Edwards Pays Boston Scientific $180M In TAVR Patent Settlement

 
• By Elizabeth Orr

Edwards Lifesciences and Boston Scientific announced this week that the firms had resolved an ongoing global patent dispute.

Two businessmen shaking hands during a meeting in the office, success, dealing, greeting & business partner concepts - soft light.
• Source: Shutterstock

More from Cardiology

More from Device Area